carcinoma of the head and neck

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma of the Head and Neck Trial in Worldwide (Talimogene Laherparepvec, Pembrolizumab)

Completed
  • Carcinoma of the Head and Neck
  • Talimogene Laherparepvec
  • Pembrolizumab
  • Newark, Delaware
  • +32 more
Aug 13, 2021

Carcinoma of the Head and Neck Trial (IMRT)

Withdrawn
  • Carcinoma of the Head and Neck
  • IMRT
  • (no location specified)
Jul 26, 2017

Carcinoma of the Head and Neck Trial in Los Angeles (Taxotere, Oxaliplatin)

Terminated
  • Carcinoma of the Head and Neck
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
May 20, 2014

Carcinoma of the Head and Neck Trial in Japan (Cetuximab)

Completed
  • Carcinoma of the Head and Neck
  • Aichi, Japan
  • +3 more
Feb 10, 2014

Head Neck Cancer, Squamous Cell Carcinoma of the Oral Cavity or Oropharynx, Head and Neck Tumors Trial in United States

Completed
  • Head and Neck Cancer
  • +3 more
  • Allovectin-7®
  • Birmingham, Alabama
  • +9 more
Jun 20, 2008